Corton Capital Inc. Iovance Biotherapeutics, Inc. Transaction History

Corton Capital Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.62 - $10.0 $27,875 - $49,600	-4,960 Reduced 30.09%	11,525 $73,000
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $60,134 - $82,724	-6,310 Reduced 27.68%	16,485 $158,000
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $10,609 - $30,482	-1,663 Reduced 6.8%	22,795 $252,000
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $96,242 - $148,483	7,774 Added 46.6%	24,458 $407,000
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $276,120 - $460,978	16,684 New	16,684 $318,000

324

244M

3.91M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $843M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.